共 122 条
[1]
Ahlawat S(2020)Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis Skelet Radiol 49 199-219
[2]
Blakeley JO(1989)Neurofibromatosis types 1 and 2: cranial MR findings Radiology 172 527-534
[3]
Langmead S(2020)Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966 Orphanet J Rare Dis 15 37-S32
[4]
Aoki S(2017)Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision J Neuroophthalmol 37 S23-S32
[5]
Barkovich AJ(2017)Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision J Neuroophthalmol 37 23-541
[6]
Nishimura K(2020)Focal areas of high signal intensity in children with neurofibromatosis type 1: expected evolution on MRI AJNR Am J Neuroradiol 29 536-811
[7]
Bergqvist C(2020)Focal areas of high signal intensity in children with neurofibromatosis type 1: expected evolution on MRI AJNR Am J Neuroradiol 148 799-2338
[8]
Servy A(2003)Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours Eur J Surg Oncol 149 2327-4121
[9]
Valeyrie-Allanore L(2018)Neurofibromatosis type 1 Handb Clin Neurol 36 4095-656
[10]
de Blank PMK(2009)Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options Am J Med Genet A 104 e49-1381